Introduction to the EQIPD quality system

While high risk of failure is an inherent part of developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Supported through the European Union’s Innovative Medicines Initiative, the EQIPD consortium has developed a novel preclinical research qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Bespalov, Anton, Bernard, René, Gilis, Anja, Gerlach, Björn, Guillén, Javier, Castagné, Vincent, Lefevre, Isabel A, Ducrey, Fiona, Monk, Lee, Bongiovanni, Sandrine, Altevogt, Bruce, Arroyo-Araujo, María, Bikovski, Lior, de Bruin, Natasja, Castaños-Vélez, Esmeralda, Dityatev, Alexander, Emmerich, Christoph H, Fares, Raafat, Ferland-Beckham, Chantelle, Froger-Colléaux, Christelle, Gailus-Durner, Valerie, Hölter, Sabine M, Hofmann, Martine CJ, Kabitzke, Patricia, Kas, Martien JH, Kurreck, Claudia, Moser, Paul, Pietraszek, Malgorzata, Popik, Piotr, Potschka, Heidrun, Prado Montes de Oca, Ernesto, Restivo, Leonardo, Riedel, Gernot, Ritskes-Hoitinga, Merel, Samardzic, Janko, Schunn, Michael, Stöger, Claudia, Voikar, Vootele, Vollert, Jan, Wever, Kimberley E, Wuyts, Kathleen, MacLeod, Malcolm R, Dirnagl, Ulrich, Steckler, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184207/
https://www.ncbi.nlm.nih.gov/pubmed/34028353
http://dx.doi.org/10.7554/eLife.63294

Ejemplares similares

Ejemplares similares